Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial
Katarzyna Jóźwik−Plebanek, Alicja Hubalewska‐Dydejczyk, Anna Borkowska, Renata Mikołajczak et al.
Citations
1 citations
Journal
Frontiers in Endocrinology
Topics
Neuroendocrine Tumor Research Advances
Field-Weighted Citation Impact (FWCI)
1.35
article
Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial
Katarzyna Jóźwik−Plebanek, Alicja Hubalewska‐Dydejczyk, Anna Borkowska, Renata Mikołajczak, Marek Saracyn, Agata Kubik, Anna Budzyńska, Joanna Długosińska, Marek Dedecjus, Agata Walęcka-Mazur, Paulina Cegła, Wioletta Lenda-Tracz, Danuta Gąsior‐Perczak, Joanna Januszkiewicz-Caulier, Aldona Kowalska, Patrycja Pastusiak, J. Braziewicz, Krzysztof Kacperski, Izabela Cieszykowska, Piotr Garnuszek, Artur Szczodry, Marta Opalińska, Adam Daniel Durma, Maciej Kołodziej, Wioletta Chalewska, Grzegorz Kamiński, Katarzyna Janiak, Małgorzata Trofimiuk–Müldner, Anna Sowa-Staszczak, Adrianna Mróz
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in EndocrinologyVol. 16
Institutions
Warsaw University of Technology (PL), Jagiellonian University (PL), National Academy of Medicine (US), Jan Kochanowski University (PL), Medical University of Warsaw (PL), National Centre for Nuclear Research (PL), National Institute of Oncology (HU), Holy Cross University (PL), University of Warsaw (PL)